Live Breaking News & Updates on Retinopathy

Stay informed with the latest breaking news from Retinopathy on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Retinopathy and stay connected to the pulse of your community

CGM Associated With Lower Retinopathy Risk in T1D

The use of continuous glucose monitoring (CGM) was linked to a reduced risk for diabetic retinopathy, a debilitating complication in adults with type 1 diabetes.

Johns-hopkins-university , Maryland , United-states , Baltimore , California , Yan-alvin-liu , Los-angeles , Estellem-everett , David-geffen-school-of-medicine , University-of-california , Johns-hopkins-university-school-of-medicine , Diabetes-center

Steps You Can Take To Protect Your Premature Infant's Vision

Retinopathy of prematurity (ROP) is a disease that has become increasingly common and significant in recent years.

Clinical-trials , Retinopathy , Retinopathy-of-prematurity , Premature-babies , Premature-baby , Vision , Baby-vision , Infant-retinopathy , Premature-infant-retinopathy , Infant-vision ,

Groundbreaking technology shows immense potential for treating ischemic retinopathy

A groundbreaking technology with immense potential in treating ischemic retinopathy in premature infants and diabetic patients has been developed by Professor Byoung Heon Kang and his research team in the Department of Biological Sciences at UNIST, in collaboration with Professor Dong Ho Park's team at Kyungpook National University Hospital. Ischemic retinopathy, characterized by the breakdown of the blood-retinal barrier and abnormal blood vessel growth, often leads to vision impairment and loss.

South-korea , Korea , Smartin-bio-inc , Department-of-biological-sciences , Kyungpook-national-university-hospital , Ulsan-national-institute-of-science , National-institute , Professor-byoung-heon-kang , Biological-sciences , Professor-dong-ho-park , Kyungpook-national-university

SGLT2 Inhibitors Protective Against Retinopathy in T2D

SGLT2 inhibitors are known to reduce diabetic nephropathy risk in patients with type 2 diabetes, but can they also protect against diabetic retinopathy?

Taiwan , Taiwanese , Fu-shun-yen , Diabetes-mellitus-type-2 , Iabetes-mellitus-type-ii , Ype-2-diabetes , Ype-2-dm , 2dm , 2d , Sglt2-inhibitors , Odium-glucose-transporter-2-inhibitors

Understanding Familial Exudative Vitreoretinopathy

Familial exudative vitreoretinopathy (FEVR) is a rare genetic disorder that affects the development of the blood vessels in the retina.

Novel-study , Molecular-genetics , Metabolism-reports , Endoplasmic-reticulum , Familial-exudative-vitreoretinopathy , Emc1 , Fevr , Eye-disease , Retinopathy , Vitreoretinopathy , Eye

WHO: Smoking Cessation Reduces Risk of Type 2 Diabetes Up to 40%

A policy brief details the risks of smoking in type 2 diabetes — along with the benefits of cessation; health professionals urged to help patients quit.

Switzerland , Geneva , Genè , Australia , Ruediger-krech , Department-of-health-promotion , World-health-organization , University-of-newcastle , World-health-organization-in-geneva , International-diabetes-federation , Health-promotion , Diabetes-mellitus-type-2

Bariatric Surgery Reduces Risk of Ocular Disease in Patients with Obesity

Findings from a retrospective cohort study highlighted the impact of bariatric surgery on postoperative ocular disease incidence, reducing the risk of future ocular morbidity.

United-states , American , Matthew-russell , American-academy-of-ophthalmology , Trinetx-united-states-collaborative-network , Cleveland-clinic-cole-eye-institute , Cleveland-clinic , Ocular-pathology-following-bariatric-surgery , Morbid-obesity-across , Paper-presented , American-academy , Primary-eye

Seeing Clearly: The Latest Treatments For Diabetic Retinopathy

Diabetic retinopathy is a silent thief that robs them of their vision. It is one of the leading causes of blindness in the working population worldwide.

Malaysia , Malaya , University-of-malaya , Vegf , Diabetic-retinopathy , Nox4 , Vision-problems , Eye-health , Vision , Vision-loss , Diabetic-vision-loss

GLP-1s Don't Appear to Worsen Diabetic Retinopathy

Most patients with diabetic retinopathy who take the GLP-1 agonist semaglutide don't experience a worsening of the condition, a new study found, but they still require screening and follow-up.

United-states , New-york , Minnesota , American , Zeeshan-haq , Vaidehi-dedania , Langone-health , American-academy-of-ophthalmology , Intelligent-research-in-sight , Centers-for-disease , Retinal-consultants , Medscape-medical

Study Shows Tarcocimab May Improve Diabetic Retinopathy

A phase 3 trial showed that tarcocimab, a biopolymer with a vascular growth factor antibody, improved vision and anatomical markers in patients with early stage diabetic retinopathy.

Udine , Friuli-venezia-giulia , Italy , United-states , Texas , American , Paolo-lanzetta , Charles-wykoff , Kodiak-sciences , University-of-udine , American-academy-of-ophthalmology , Blanton-eye-institute-of-houston-methodist-hospital